FOXO transcription factors both suppress and support breast cancer progression

Publication date

2018-05-01

Authors

Hornsveld, M
Smits, Lydia M.M.
Meerlo, Maaike
van Amersfoort, MISNI 0000000395776858
Groot Koerkamp, Marian J A
van Leenen, Dik
Kloet, D E A
Holstege, Frank C PISNI 000000014099129X
Derksen, PatrickORCID 0000-0003-0732-7762ISNI 0000000392612647
Burgering, Boudewijn M TORCID 0000-0002-4044-9596ISNI 0000000391409962

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

FOXO transcription factors are regulators of cellular homeostasis and putative tumor suppressors, yet the role of FOXO in cancer progression remains to be determined. The data on FOXO function, particularly for epithelial cancers, are fragmentary and come from studies that focused on isolated aspects of cancer. To clarify the role of FOXO in epithelial cancer progression, we characterized the effects of inducible FOXO activation and loss in a mouse model of metastatic invasive lobular carcinoma. Strikingly, either activation or loss of FOXO function suppressed tumor growth and metastasis. We show that the multitude of cellular processes critically affected by FOXO function include proliferation, survival, redox homeostasis, and PI3K signaling, all of which must be carefully balanced for tumor cells to thrive. Significance: FOXO proteins are not solely tumor suppressors, but also support tumor growth and metastasis by regulating a multitude of cellular processes essential for tumorigenesis.

Keywords

Taverne, Oncology, Cancer Research, Journal Article

Citation

Hornsveld, M, Smits, L M M, Meerlo, M, Van Amersfoort, M, Groot Koerkamp, M J A, van Leenen, D, Kloet, D E A, Holstege, F C P, Derksen, P W B, Burgering, B M T & Dansen, T B 2018, 'FOXO transcription factors both suppress and support breast cancer progression', Cancer Research, vol. 78, no. 9, pp. 2356-2369. https://doi.org/10.1158/0008-5472.CAN-17-2511